Understanding resistance to combination chemotherapy
available in PMC 2014 April 04
Main Authors: | Pritchard, Justin R. (Contributor), Hemann, Michael (Contributor), Lauffenburger, Douglas A (Author) |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biological Engineering (Contributor), Massachusetts Institute of Technology. Department of Biology (Contributor), Lauffenburger, Douglas A. (Contributor) |
Format: | Article |
Language: | English |
Published: |
Elsevier B.V.,
2014-08-21T16:17:33Z.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Addressing Genetic Tumor Heterogeneity through Computationally Predictive Combination Therapy
by: Zhao, Boyang, et al.
Published: (2014) -
Defining principles of combination drug mechanisms of action
by: Bruno, Peter Michael, et al.
Published: (2013) -
Modeling Tumor Clonal Evolution for Drug Combinations Design
by: Zhao, Boyang, et al.
Published: (2018) -
Predicting cancer drug mechanisms of action using molecular network signatures
by: Pritchard, Justin R., et al.
Published: (2014) -
Intratumor heterogeneity alters most effective drugs in designed combinations
by: Zhao, Boyang, et al.
Published: (2015)